Stock analysis, AI verdict, fundamentals & technical signals
Rating: NEUTRAL
Price: $144.43 Analyst target: $277.86 Upside: 92.38%
Axsome Therapeutics, Inc., a biopharmaceutical company, is dedicated to developing new therapies for central nervous system (CNS) disorders in the United States. The company is headquartered in New York, New York.
See the full interactive analysis & chart →Informational only — not investment advice.